Objective
To illustrate the positive impact on enrollment, retention, and patient burden of deploying a decentralized clinical trial (DCT) and a well-trained team of mobile nurses to a phase 2 exploratory study of hydroxychloroquine dosing and adherence among children with lupus.

**Objective**
To illustrate the positive impact on enrollment, retention, and patient burden of deploying a decentralized clinical trial (DCT) and a well-trained team of mobile nurses to a phase 2 exploratory study of hydroxychloroquine dosing and adherence among children with lupus.

Combining DCT Technology, Effective Mobile Nursing and Connected Devices To Deliver Pediatric Clinical Trials At Home

DIA Europe 2022

A global, member-driven non-profit organization mobilizing life sciences and healthcare. DIA fosters innovation to improve health and well-being worldwide. Professionals from 80 countries continue to engage with DIA through our unparalleled membership network, educational offerings, and professional development opportunities.